Bulletin
Investor Alert

Illumina Inc.

NAS: ILMN

GO

Set Alerts

Market Index

Overview Profile Charts Financials Historical Quotes Analyst Estimates Options SEC Filings Insiders
/marketstate/country/us
Illumina Inc.

After Hours

 --Quotes are delayed by 20 min

Mar 31, 2023, 7:58 p.m.

ILMN
/zigman2/quotes/203509482/composite

$

232.80

Change

+0.25 +0.11%

Volume

Volume 59,400

Quotes are delayed by 20 min

/zigman2/quotes/203509482/composite

Previous close

$ 225.26

$ 232.55

Change

+7.29 +3.24%

Day low

Day high

$225.65

$232.81

Open

52 week low

52 week high

$173.45

$371.16

Open

Insider Actions for Illumina Inc.

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
02/22/2023 Alex Aravanis
SVP, Chief Technology Officer 		2,320   Disposition at $202.16 per share. 469,011
02/22/2023 Alex Aravanis
SVP, Chief Technology Officer 		3,078   Disposition at $201.42 per share. 619,970
02/21/2023 Francis A. deSouza
President and CEO; Director 		10,907   Derivative/Non-derivative trans. at $202.84 per share. 2,212,375
02/21/2023 Susan H. Tousi
SVP, Chief Commercial Officer 		2,197   Derivative/Non-derivative trans. at $202.84 per share. 445,639
02/21/2023 Joydeep Goswami
SVP Chief Financial Officer 		1,640   Derivative/Non-derivative trans. at $202.84 per share. 332,657
02/21/2023 Charles E. Dadswell
SVP & General Counsel 		1,907   Derivative/Non-derivative trans. at $202.84 per share. 386,815
02/21/2023 Phillip G. Febbo
SVP Chief Medical Officer 		1,245   Derivative/Non-derivative trans. at $202.84 per share. 252,535
02/21/2023 Kevin Pegels
Chief of Global Operations 		409   Derivative/Non-derivative trans. at $202.84 per share. 82,961
02/21/2023 Aimee Hoyt
SVP, Chief People Officer 		1,365   Derivative/Non-derivative trans. at $202.84 per share. 276,876
02/21/2023 Kathryne Reeves
SVP, Chief Marketing Officer 		704   Derivative/Non-derivative trans. at $202.84 per share. 142,799
02/21/2023 Alex Aravanis
SVP, Chief Technology Officer 		3,894   Derivative/Non-derivative trans. at $202.84 per share. 789,858
02/21/2023 Francis A. deSouza
President and CEO; Director 		23,473   Derivative/Non-derivative trans. at $0 per share. 0
02/21/2023 Susan H. Tousi
SVP, Chief Commercial Officer 		5,869   Derivative/Non-derivative trans. at $0 per share. 0
02/21/2023 Joydeep Goswami
SVP Chief Financial Officer 		4,696   Derivative/Non-derivative trans. at $0 per share. 0
02/21/2023 Charles E. Dadswell
SVP & General Counsel 		5,282   Derivative/Non-derivative trans. at $0 per share. 0
02/21/2023 Phillip G. Febbo
SVP Chief Medical Officer 		3,522   Derivative/Non-derivative trans. at $0 per share. 0
02/21/2023 Kevin Pegels
Chief of Global Operations 		1,097   Derivative/Non-derivative trans. at $0 per share. 0
02/21/2023 Aimee Hoyt
SVP, Chief People Officer 		5,282   Derivative/Non-derivative trans. at $0 per share. 0
02/21/2023 Kathryne Reeves
SVP, Chief Marketing Officer 		2,789   Derivative/Non-derivative trans. at $0 per share. 0
02/21/2023 Alex Aravanis
SVP, Chief Technology Officer 		9,292   Derivative/Non-derivative trans. at $0 per share. 0
02/06/2023 Susan H. Tousi
SVP, Chief Commercial Officer 		500   Disposition at $211.57 per share. 105,785
01/09/2023 Aimee Hoyt
SVP, Chief People Officer 		871   Disposition at $205.57 per share. 179,051
01/06/2023 Susan H. Tousi
SVP, Chief Commercial Officer 		500   Disposition at $204.58 per share. 102,290
12/06/2022 Susan H. Tousi
SVP, Chief Commercial Officer 		500   Disposition at $212.63 per share. 106,315
11/08/2022 Alex Aravanis
SVP, Chief Technology Officer 		361   Disposition at $218 per share. 78,698
11/07/2022 Susan H. Tousi
SVP, Chief Commercial Officer 		500   Disposition at $223.65 per share. 111,825
11/07/2022 Aimee Hoyt
SVP, Chief People Officer 		1,045   Disposition at $223.65 per share. 233,714
11/07/2022 Aimee Hoyt
SVP, Chief People Officer 		1,294   Disposition at $223.65 per share. 289,403
11/05/2022 Francis A. deSouza
President and CEO; Director 		2,591   Derivative/Non-derivative trans. at $217.19 per share. 562,739
11/05/2022 Susan H. Tousi
SVP, Chief Commercial Officer 		721   Derivative/Non-derivative trans. at $217.19 per share. 156,593
11/05/2022 Joydeep Goswami
SVP Chief Financial Officer 		638   Derivative/Non-derivative trans. at $217.19 per share. 138,567
11/05/2022 Charles E. Dadswell
SVP & General Counsel 		853   Derivative/Non-derivative trans. at $217.19 per share. 185,263
11/05/2022 Phillip G. Febbo
SVP Chief Medical Officer 		821   Derivative/Non-derivative trans. at $217.19 per share. 178,312
11/05/2022 Kevin Pegels
Chief of Global Operations 		472   Derivative/Non-derivative trans. at $217.19 per share. 102,513
11/05/2022 Aimee Hoyt
SVP, Chief People Officer 		640   Derivative/Non-derivative trans. at $217.19 per share. 139,001
11/05/2022 Scott Ericksen
VP, Chief Accounting Officer 		213   Derivative/Non-derivative trans. at $217.19 per share. 46,261
11/05/2022 Kathryne Reeves
SVP, Chief Marketing Officer 		212   Derivative/Non-derivative trans. at $217.19 per share. 46,044
11/05/2022 Alex Aravanis
SVP, Chief Technology Officer 		191   Derivative/Non-derivative trans. at $217.19 per share. 41,483
10/06/2022 Susan H. Tousi
SVP, Chief Commercial Officer 		500   Disposition at $216.59 per share. 108,295
Copyright 2023 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.

Transaction Summary

Total insider purchases and sales reported to the SEC

Timeframe Transactions Shares
Last 3 months
9 Purchases
14 Sales
61,302
31,537
Last 6 months
9 Purchases
32 Sales
61,302
43,327
Last 12 months
19 Purchases
49 Sales
74,247
50,260

Officers and Executives

Mr. Francis A. deSouza
President, Chief Executive Officer & Director
Mr. Kevin Pegels
Chief-Global Operations
Dr. Joydeep Goswami
CFO, Chief Strategy & Development Officer
Dr. Alex Aravanis
CTO, Head-Research & Product Development
Ms. Carissa Rollins
Chief Information Officer
Dr. Phillip G. Febbo
Chief Medical Officer
Ms. Susan H. Tousi
Chief Commercial Officer
Dr. Craig Michael Ciesla
Vice President
Dr. Bryan Crane
Vice President & Head-System Design
Mr. Charles E. Dadswell
Secretary & General Counsel
Ms. Kathryne Reeves
Chief Marketing Officer
Mr. Scott Ericksen
Chief Accounting Officer & Vice President
Ms. Sallilyn Schwartz
Vice President-Investor Relations
Ms. Aimee Hoyt
Chief People Officer
Mr. John Frank
Chief Public Affairs Officer
Dr. John Wendell Thompson
Chairman
Dr. Scott Gottlieb
Independent Director
Dr. Robert S. Epstein
Independent Director
Dr. Frances Hamilton Arnold
Independent Director
Mr. Philip W. Schiller
Independent Director
Ms. Caroline D. Dorsa
Independent Director
Dr. Gary S. Guthart
Independent Director
Ms. Susan E. Siegel
Independent Director
Link to MarketWatch's Slice.